Item Details
JSR acquisition creates potential business disposal opportunities
Mitsui has indicated that it plans to sell JSR's life sciences business and other non-core assets as part of its wider restructuring. HPC could identify potential buyers, investment firms and strategic partners for these businesses. This is a potential future mandate rather than an announced sale process, so buyer interest and the disposal timetable would need to be verified. [Reuters]
Get in Touch
We’ll get back to you shortly.